U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07519980) titled 'Xanthigen and Its Impact on Weight and Metabolic Health' on Jan. 26.

Brief Summary: Randomized, controlled, triple-blind clinical trial with three parallel arms based on the product consumed (low-dose experimental product, high-dose experimental product, and placebo product) and conducted at a single center to measure the efficacy of a product (Xanthigen(R)) on overweight or obesity during 16 weeks of consumption.

Study Start Date: Feb. 02

Study Type: INTERVENTIONAL

Condition: Obesity & Overweight

Intervention: DIETARY_SUPPLEMENT: Experimental group: Xanthigen(R)

They will take one capsule per day.

DIETARY_SUPPLEMENT: Contr...